시장보고서
상품코드
1574983

조류인플루엔자 치료 시장 : 균주 유형별, 치료 유형별, 투여 방법별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Bird Flu Treatment Market, By Strain Type, By Treatment Type, By Mode of Administration, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 311 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

조류인플루엔자 치료 시장 규모는 2023년 168억 9,732만 달러로 2024년부터 2032년까지 CAGR 10.68%로 확대될 것으로 예상됩니다.

조류인플루엔자 치료 시장 - 시장 역학

조류인플루엔자 발생률 증가로 조류인플루엔자 치료 시장에서 효과적인 치료 솔루션에 대한 수요가 증가

조류인플루엔자 발생률의 증가는 조류인플루엔자 치료 시장에서 효과적인 치료 솔루션에 대한 수요를 크게 촉진하고 있습니다. 세계보건기구(WHO)에 따르면, 조류독감 발생은 30개국 이상에서 보고되고 있으며, 감염 확산을 막기 위해 수백만 마리의 조류가 살처분되고 있습니다. 미국 질병예방통제센터(CDC)는 인체 감염 사례는 아직 드물지만, 인수공통전염병의 위험은 발생과 함께 높아질 것이라며 각국 정부에 대비와 대응 전략을 강화할 것을 촉구하고 있습니다. 이에 따라 제약사들은 조류인플루엔자 균주에 특화된 백신과 항바이러스 치료제 개발에 박차를 가하고 있습니다. 예를 들어, 미국 농무부는 다양한 조류인플루엔자 아형에 대한 백신의 효능을 개선하고 신속한 대응 능력을 확보하기 위한 연구에 투자하고 있습니다. 공중 보건과 가금류 산업에 미치는 잠재적 영향에 대한 인식이 높아짐에 따라 시장에서는 조류인플루엔자 치료 솔루션에 대한 투자와 기술 혁신이 증가하고 있습니다.

조류인플루엔자 치료 시장 - 주요 인사이트

리서치 애널리스트의 분석에 따르면, 세계 시장은 예측 기간(2024-2032년) 동안 연평균 약 10.68%의 CAGR로 매년 성장할 것으로 예상됩니다.

균주 유형별로는 H5N1이 2023년에 가장 큰 시장 점유율을 보일 것으로 예측됐습니다.

치료 유형별로는 2023년 백신이 주요 유형으로 부상했습니다.

투여 방법별로는 2023년 피내 주사가 주요 유형으로 나타났습니다.

지역별로는 아시아태평양이 2023년 주요 수익원으로 꼽혔습니다.

조류인플루엔자 치료 시장 - 세분화 분석:

세계 조류인플루엔자 치료 시장은 균주 유형, 치료 유형, 투여 방법, 최종사용자 및 지역에 따라 세분화됩니다.

시장 유형별로는 H5N1, H7N9, H5N8의 세 가지 범주로 나눌 수 있는데, H5N1은 조류와 인간 모두에서 높은 사망률을 보여 조류인플루엔자 치료 시장을 주도하고 있으며, H7N9는 인수공통전염병이 될 가능성이 높아 주목받고 있고, H5N8은 전염성이 낮지만 최근 발생이 계속 우려되고 있습니다.는 낮은 감염력에도 불구하고 최근 발생으로 인해 여전히 우려되고 있습니다.

치료 유형에 따라 시장은 항바이러스제, 백신, 대증요법, 면역요법 등 4가지 범주로 나뉩니다. 조류인플루엔자 치료 시장은 조류인플루엔자 발생에 대한 주요 예방책으로 백신이 대부분을 차지하고 있습니다. 항바이러스제가 그 뒤를 이어 감염된 환자에게 필수적인 치료 옵션을 제공하고 있습니다. 대증요법은 환자의 편안함을 위해 중요하며, 면역요법이 부상하고 있지만 아직 널리 보급되지는 않았습니다.

조류인플루엔자 치료 시장 - 지리적 인사이트

조류인플루엔자 치료 시장은 지역별로 큰 차이를 보이고 있으며, 그 중에서도 아시아태평양은 조류독감이 많이 발생하는 지역으로 시장을 주도하고 있습니다. 중국과 인도와 같은 국가에서는 많은 수의 사례가 보고되어 확산을 억제하기 위한 정부의 강력한 노력을 촉구하고 있습니다. 중국에서는 가금류에 대한 백신 접종 프로그램을 포함한 엄격한 생물 보안 조치를 시행하여 발병의 영향을 완화하기 위해 농촌 농업 및 농촌 부서가 시행하고 있습니다. 북미가 그 뒤를 이어 미국에서는 몇 차례의 대규모 발병에 직면하여 피해 가금류에 대한 대대적인 살처분과 미국 농무부의 백신 및 치료법 연구에 대한 자금 지원이 증가했습니다. 유럽도 중요한 역할을 하고 있으며, 유럽식품안전청(EFSA)은 조류독감을 면밀히 모니터링하고 있습니다. 한편, 중동에서는 산발적인 발생이 나타나고 있으며, 이집트와 같은 국가들은 감시와 신속한 대응에 중점을 두어 감염을 억제하기 위해 노력하고 있습니다. 이들 지역이 조류인플루엔자 대응을 강화함에 따라 효과적인 치료법에 대한 수요가 계속 증가하고 있으며, 이는 시장의 역동적 인 특성을 강조하고 있습니다.

조류인플루엔자 치료 시장 - 경쟁 상황:

조류인플루엔자 치료 시장은 베링거인겔하임, 조에티스, 머크동물건강 등 주요 기업들을 중심으로 경쟁이 치열해지고 있습니다. 베링거인겔하임은 조류인플루엔자에 대한 효과적인 백신을 개발하기 위해 여러 농무부와 협력하여 큰 진전을 이루었고 그 결과, 조류인플루엔자 발생 지역에서 수백만 마리의 가금류에 백신을 접종하는 데 성공했습니다. 동물용 의약품의 선두주자인 조에티스는 새로운 조류독감 백신 시리즈를 출시하며 혁신에 집중하고 있으며, 가금류 사육의 바이오 보안 강화를 위한 노력을 강화하고 있습니다. 또한, 머크 동물 건강은 세계동물보건기구(OIE)와 협력하여 조류인플루엔자 발생 시 감시 및 신속한 대응 전략을 개선하여 전 세계 가금류 생산에 미치는 영향을 최소화하기 위해 노력하고 있습니다. 이들 기업은 효과적인 치료법과 예방책을 개발하기 위해 연구 개발에 적극적으로 투자하고 있으며, 전략적 파트너십을 통해 시장 범위를 확장하고 전체 조류인플루엔자 치료 시장의 성장에 기여하고 있습니다.

목차

제1장 조류인플루엔자 치료 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 조류인플루엔자 치료의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 전망 동향

제4장 조류인플루엔자 치료 산업 조사

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 매핑
  • 규제 프레임워크 분석

제5장 조류인플루엔자 치료 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 조류인플루엔자 치료 시장 상황

  • 조류인플루엔자 치료 시장 점유율 분석, 2023년
  • 주요 제조업체별 내역 데이터
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 조류인플루엔자 치료 시장 - 균주 유형별

  • 개요
    • 균주 유형별 부문 점유율 분석
    • H5N1
    • H7N9
    • H5N8
    • 기타

제8장 조류인플루엔자 치료 시장 - 치료 유형별

  • 개요
    • 치료 유형별 부문 점유율 분석
    • 항바이러스제
    • 백신
    • 대증요법
    • 면역요법

제9장 조류인플루엔자 치료 시장 - 투여 방법별

  • 개요
    • 투여 방법별 부문 점유율 분석
    • 경구
    • 정맥내
    • 흡입

제10장 조류인플루엔자 치료 시장 - 최종사용자별

  • 개요
    • 최종사용자별 부문 점유율 분석
    • 병원
    • 클리닉
    • 조사기관
    • 정부기관

제11장 조류인플루엔자 치료 시장 - 지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제12장 주요 벤더 분석 - 조류인플루엔자 치료 업계

  • 경쟁 대시보드
  • 기업 개요
    • Amgen Inc.
    • AstraZeneca PLC
    • Bharat Biotech International Ltd.
    • BioCryst Pharmaceuticals, Inc.
    • Cipla Limited
    • CSL Limited(Seqirus)
    • Daiichi Sankyo Company, Limited
    • Dr. Reddy's Laboratories Ltd.
    • GlaxoSmithKline plc
    • Johnson & Johnson Services, Inc.
    • Merck &Co., Inc.
    • Mylan NV(part of Viatris Inc.)
    • Novartis International AG
    • Pfizer Inc.
    • Roche Holding AG
    • Sanofi SA
    • Others

제13장 애널리스트의 전방위 전망

ksm 24.11.05

REPORT HIGHLIGHT

Bird Flu Treatment Market size was valued at USD 16,897.32 Million in 2023, expanding at a CAGR of 10.68% from 2024 to 2032.

The Bird Flu Treatment Market focuses on the development and distribution of therapies and vaccines to combat avian influenza infections in birds and potential zoonotic transmissions to humans. The market is expanding due to the rising incidence of bird flu outbreaks worldwide, with the World Organisation for Animal Health (OIE) reporting over 1,000 cases in various countries in 2021. Growing concerns about the impact of bird flu on poultry farming and public health are driving demand for effective treatments and preventive measures. However, challenges such as high costs associated with vaccine development and production, alongside regulatory hurdles, can hinder market growth. Opportunities lie in advancements in vaccine technology and increased investment in research to develop more effective antiviral drugs. Additionally, heightened awareness and surveillance programs initiated by governments and health organizations to monitor and control avian influenza outbreaks are likely to foster growth in the market, as they emphasize the need for prompt and effective treatments.

Bird Flu Treatment Market- Market Dynamics

Rising Incidence of Bird Flu Fuels Demand for Effective Treatment Solutions in the Bird Flu Treatment Market

The rising incidence of bird flu is significantly fueling demand for effective treatment solutions in the Bird Flu Treatment Market. According to the World Health Organization (WHO), avian influenza outbreaks have been reported in over 30 countries, leading to the culling of millions of birds to prevent spread. The Centers for Disease Control and Prevention (CDC) highlights that while human cases remain rare, the risk of zoonotic transmission increases with outbreaks, prompting governments to enhance their preparedness and response strategies. In response, pharmaceutical companies are accelerating the development of vaccines and antiviral treatments specifically targeting avian influenza strains. For example, the U.S. Department of Agriculture has invested in research to improve vaccine efficacy against various bird flu subtypes, ensuring rapid response capabilities. As awareness grows regarding the potential impact on public health and the poultry industry, the market is witnessing increased investment and innovation in bird flu treatment solutions.

Bird Flu Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.68% over the forecast period (2024-2032)

Based on Strain Type segmentation, H5N1 was predicted to show maximum market share in the year 2023

Based on Treatment Type segmentation, Vaccines was the leading type in 2023

Based on Mode of Administration segmentation, Intradermal Injection was the leading type in 2023

On the basis of region, Asia-Pacific was the leading revenue generator in 2023

Bird Flu Treatment Market- Segmentation Analysis:

The Global Bird Flu Treatment Market is segmented on the basis of Strain Type, Treatment Type, Mode of Administration, End-User, and Region.

The market is divided into three categories based on Strain Type: H5N1, H7N9, and H5N8. H5N1 leads the Bird Flu Treatment Market due to its high mortality rate in both birds and humans. H7N9 follows, noted for its significant zoonotic potential, while H5N8, though less transmissible, remains a concern due to recent outbreaks.

The market is divided into four categories based on Treatment Type: Antiviral Drugs, Vaccines, Symptomatic Care, and Immunotherapy. Vaccines dominate the Bird Flu Treatment Market as the primary preventive measure against avian influenza outbreaks. Antiviral drugs follow, providing essential treatment options for infected individuals. Symptomatic care is important for patient comfort, while immunotherapy is emerging but remains less prevalent.

Bird Flu Treatment Market- Geographical Insights

The Bird Flu Treatment Market exhibits significant regional variations, with Asia-Pacific leading due to its high prevalence of avian influenza outbreaks. Countries like China and India have reported numerous cases, prompting robust government initiatives to control the spread. In China, the Ministry of Agriculture and Rural Affairs has implemented strict biosecurity measures, including vaccination programs for poultry, which have helped mitigate outbreak impacts. North America follows, where the U.S. has faced several outbreaks, leading to substantial culling of affected poultry and increased funding for research into vaccines and treatments by the USDA. Europe also plays a crucial role, with the European Food Safety Authority (EFSA) monitoring avian influenza closely, and various countries adopting vaccination strategies to protect domestic flocks. Meanwhile, the Middle East has seen sporadic outbreaks, with countries like Egypt emphasizing surveillance and rapid response initiatives to curb transmission. As these regions intensify their efforts to combat bird flu, the demand for effective treatments continues to rise, highlighting the market's dynamic nature.

Bird Flu Treatment Market- Competitive Landscape:

The Bird Flu Treatment Market is competitive, featuring key players like Boehringer Ingelheim, Zoetis, and Merck Animal Health. Boehringer Ingelheim has made significant strides by collaborating with various agricultural ministries to develop effective vaccines against avian influenza, resulting in the successful vaccination of millions of poultry in affected regions. Zoetis, a leader in animal health, has focused on innovation by launching a new line of avian influenza vaccines, reinforcing its commitment to enhancing biosecurity in poultry farming. Additionally, Merck Animal Health has partnered with the World Organisation for Animal Health (OIE) to improve surveillance and rapid response strategies for avian influenza outbreaks, aiming to minimize the impact on global poultry production. These companies are actively investing in research and development to create effective treatments and preventive measures, while strategic partnerships enhance their market reach and contribute to overall growth in the Bird Flu Treatment Market.

Recent Developments:

In July 2024, the World Health Organization (WHO) announced a new project to accelerate the development of a bird flu vaccine in poorer countries. The project uses messenger RNA technology and is led by Argentinian manufacturer Sinergium Biotech.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIRD FLU TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Amgen Inc.
  • AstraZeneca PLC
  • Bharat Biotech International Ltd.
  • BioCryst Pharmaceuticals, Inc.
  • Cipla Limited
  • CSL Limited (Seqirus)
  • Daiichi Sankyo Company, Limited
  • Dr. Reddy's Laboratories Ltd.
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Mylan N.V. (part of Viatris Inc.)
  • Novartis International AG
  • Pfizer Inc.
  • Roche Holding AG
  • Sanofi S.A.
  • Others

GLOBAL BIRD FLU TREATMENT MARKET, BY STRAIN TYPE- MARKET ANALYSIS, 2019 - 2032

  • H5N1
  • H7N9
  • H5N8
  • Others

GLOBAL BIRD FLU TREATMENT MARKET, BY TREATMENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Antiviral Drugs
  • Vaccines
  • Symptomatic Care
  • Immunotherapy

GLOBAL BIRD FLU TREATMENT MARKET, BY MODE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Oral
  • Intravenous
  • Inhalation

GLOBAL BIRD FLU TREATMENT MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Research Institutes
  • Government Agencies

GLOBAL BIRD FLU TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Bird Flu Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Bird Flu Treatment Market Snippet by Strain Type
    • 2.1.2. Bird Flu Treatment Market Snippet by Treatment Type
    • 2.1.3. Bird Flu Treatment Market Snippet by Mode of Administration
    • 2.1.4. Bird Flu Treatment Market Snippet by End-User
    • 2.1.5. Bird Flu Treatment Market Snippet by Country
    • 2.1.6. Bird Flu Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Bird Flu Treatment Key Market Trends

  • 3.1. Bird Flu Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Bird Flu Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Bird Flu Treatment Market Opportunities
  • 3.4. Bird Flu Treatment Market Future Trends

4. Bird Flu Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Bird Flu Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Bird Flu Treatment Market Landscape

  • 6.1. Bird Flu Treatment Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Bird Flu Treatment Market - By Strain Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Strain Type, 2023 & 2032 (%)
    • 7.1.2. H5N1
    • 7.1.3. H7N9
    • 7.1.4. H5N8
    • 7.1.5. Others

8. Bird Flu Treatment Market - By Treatment Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Treatment Type, 2023 & 2032 (%)
    • 8.1.2. Antiviral Drugs
    • 8.1.3. Vaccines
    • 8.1.4. Symptomatic Care
    • 8.1.5. Immunotherapy

9. Bird Flu Treatment Market - By Mode of Administration

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Mode of Administration, 2023 & 2032 (%)
    • 9.1.2. Oral
    • 9.1.3. Intravenous
    • 9.1.4. Inhalation

10. Bird Flu Treatment Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Clinics
    • 10.1.4. Research Institutes
    • 10.1.5. Government Agencies

11. Bird Flu Treatment Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Bird Flu Treatment Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Bird Flu Treatment Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Bird Flu Treatment Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Bird Flu Treatment Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Bird Flu Treatment Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Strain Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Bird Flu Treatment Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Amgen Inc.
    • 12.2.2. AstraZeneca PLC
    • 12.2.3. Bharat Biotech International Ltd.
    • 12.2.4. BioCryst Pharmaceuticals, Inc.
    • 12.2.5. Cipla Limited
    • 12.2.6. CSL Limited (Seqirus)
    • 12.2.7. Daiichi Sankyo Company, Limited
    • 12.2.8. Dr. Reddy's Laboratories Ltd.
    • 12.2.9. GlaxoSmithKline plc
    • 12.2.10. Johnson & Johnson Services, Inc.
    • 12.2.11. Merck & Co., Inc.
    • 12.2.12. Mylan N.V. (part of Viatris Inc.)
    • 12.2.13. Novartis International AG
    • 12.2.14. Pfizer Inc.
    • 12.2.15. Roche Holding AG
    • 12.2.16. Sanofi S.A.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제